Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
Lee DJ, Pajak TF, Stetz J, Order SE, Weissberg JB, Fischer JJ. Lee DJ, et al. Among authors: stetz j. Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):465-70. doi: 10.1016/0360-3016(89)90343-x. Int J Radiat Oncol Biol Phys. 1989. PMID: 2646255 Clinical Trial.
Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
Marcial VA, Pajak TF, Chang C, Tupchong L, Stetz J. Marcial VA, et al. Among authors: stetz j. Int J Radiat Oncol Biol Phys. 1987 Jan;13(1):41-7. doi: 10.1016/0360-3016(87)90258-6. Int J Radiat Oncol Biol Phys. 1987. PMID: 3542916 Clinical Trial.
54 results